Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ribociclib induced acute kidney injury: A case report.
Gulturk I, Yilmaz M, Ozmen A, Tacar SY, Erdal GS, Tural D. Gulturk I, et al. Among authors: tacar sy. J Oncol Pharm Pract. 2021 Dec;27(8):2023-2026. doi: 10.1177/10781552211007202. Epub 2021 Apr 13. J Oncol Pharm Pract. 2021. PMID: 33847193
Nivolumab induced hypophysitis in an advanced RCC patient.
Korkmaz Yilmaz M, Gulturk I, Tacar SY, Yilmaz M. Korkmaz Yilmaz M, et al. Among authors: tacar sy. J Oncol Pharm Pract. 2022 Apr;28(3):759-762. doi: 10.1177/10781552211072212. Epub 2022 Jan 10. J Oncol Pharm Pract. 2022. PMID: 35006033
Lutetium-Associated Myopathy: A Case Report.
Gulturk I, Sonmezoz GB, Yilmaz M, Tacar SY, Ozmen A, Erdal GS, Nalbant MO, Tural D. Gulturk I, et al. Among authors: tacar sy. Am J Ther. 2024 Jan-Feb 01;31(1):e81-e84. doi: 10.1097/MJT.0000000000001491. Epub 2022 Mar 24. Am J Ther. 2024. PMID: 35383588 No abstract available.
Thirty-day mortality rates after immunotherapy initiation.
Sütcüoğlu O, İlhan A, Tacar SY, Güven DC, Uçar G, Karadurmuş N, Yıldız F, Eraslan E, Uncu D, Tural D, Üner A, Günel N, Özdemir N, Kılıçkap S, Öksüzoğlu ÖB, Özet A, Yazıcı O. Sütcüoğlu O, et al. Among authors: tacar sy. Immunotherapy. 2021 Dec;13(17):1419-1426. doi: 10.2217/imt-2021-0082. Epub 2021 Oct 22. Immunotherapy. 2021. PMID: 34676791
Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?
Ocak B, Sahin AB, Ertürk I, Korkmaz M, Erdem D, Cakıroglu U, Karaca M, Dirican A, Olmez OF, Goktas Aydın S, Gökyer A, Kücükarda A, Gülmez A, Yumuk PF, Demircan NC, Oyman A, Sakalar T, Karatas F, Demir H, Yasin AI, Deligonul A, Dakiki B, Goktug MR, Avcı O, Tacar SY, Turhal NS, Deniz GI, Kacan T, Cubukcu E, Evrensel T. Ocak B, et al. Among authors: tacar sy. Curr Oncol. 2024 Sep 4;31(9):5195-5205. doi: 10.3390/curroncol31090384. Curr Oncol. 2024. PMID: 39330012 Free PMC article.
12 results